209 related articles for article (PubMed ID: 21063400)
1. Rab25 as a tumour suppressor in colon carcinogenesis.
Goldenring JR; Nam KT
Br J Cancer; 2011 Jan; 104(1):33-6. PubMed ID: 21063400
[TBL] [Abstract][Full Text] [Related]
2. Loss of Rab25 promotes the development of intestinal neoplasia in mice and is associated with human colorectal adenocarcinomas.
Nam KT; Lee HJ; Smith JJ; Lapierre LA; Kamath VP; Chen X; Aronow BJ; Yeatman TJ; Bhartur SG; Calhoun BC; Condie B; Manley NR; Beauchamp RD; Coffey RJ; Goldenring JR
J Clin Invest; 2010 Mar; 120(3):840-9. PubMed ID: 20197623
[TBL] [Abstract][Full Text] [Related]
3. Loss of Rab25 promotes the development of skin squamous cell carcinoma through the dysregulation of integrin trafficking.
Jeong H; Lim KM; Kim KH; Cho Y; Lee B; Knowles BC; Roland JT; Zwerner JP; Goldenring JR; Nam KT
J Pathol; 2019 Oct; 249(2):227-240. PubMed ID: 31144312
[TBL] [Abstract][Full Text] [Related]
4. Rab25 in cancer: a brief update.
Mitra S; Cheng KW; Mills GB
Biochem Soc Trans; 2012 Dec; 40(6):1404-8. PubMed ID: 23176489
[TBL] [Abstract][Full Text] [Related]
5. Rab25 regulates integrin expression in polarized colonic epithelial cells.
Krishnan M; Lapierre LA; Knowles BC; Goldenring JR
Mol Biol Cell; 2013 Mar; 24(6):818-31. PubMed ID: 23345591
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor function of Rab25 in triple-negative breast cancer.
Cheng JM; Volk L; Janaki DK; Vyakaranam S; Ran S; Rao KA
Int J Cancer; 2010 Jun; 126(12):2799-812. PubMed ID: 19795443
[TBL] [Abstract][Full Text] [Related]
7. Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesis.
Bhat AA; Pope JL; Smith JJ; Ahmad R; Chen X; Washington MK; Beauchamp RD; Singh AB; Dhawan P
Oncogene; 2015 Aug; 34(35):4570-80. PubMed ID: 25500541
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles for Rab family GTPases in human cancer.
Chia WJ; Tang BL
Biochim Biophys Acta; 2009 Apr; 1795(2):110-6. PubMed ID: 19425190
[TBL] [Abstract][Full Text] [Related]
9. The action of small GTPases Rab11 and Rab25 in vesicle trafficking during cell migration.
Kessler D; Gruen GC; Heider D; Morgner J; Reis H; Schmid KW; Jendrossek V
Cell Physiol Biochem; 2012; 29(5-6):647-56. PubMed ID: 22613965
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of RAB25 expression by RNAi inhibits growth of human epithelial ovarian cancer cells in vitro and in vivo.
Fan Y; Xin XY; Chen BL; Ma X
Pathology; 2006 Dec; 38(6):561-7. PubMed ID: 17393986
[TBL] [Abstract][Full Text] [Related]
11. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers.
Cheng KW; Lahad JP; Kuo WL; Lapuk A; Yamada K; Auersperg N; Liu J; Smith-McCune K; Lu KH; Fishman D; Gray JW; Mills GB
Nat Med; 2004 Nov; 10(11):1251-6. PubMed ID: 15502842
[TBL] [Abstract][Full Text] [Related]
12. Is Rab25 a tumor promoter or suppressor--context dependency on RCP status?
Tang BL
Tumour Biol; 2010 Aug; 31(4):359-61. PubMed ID: 20376596
[TBL] [Abstract][Full Text] [Related]
13. Transformation of rat intestinal epithelial cells by overexpression of Rab25 is microtubule dependent.
Lapierre LA; Caldwell CM; Higginbotham JN; Avant KM; Hall J; Beauchamp RD; Goldenring JR
Cytoskeleton (Hoboken); 2011 Feb; 68(2):97-111. PubMed ID: 21246754
[TBL] [Abstract][Full Text] [Related]
14. Identification of a small GTP-binding protein, Rab25, expressed in the gastrointestinal mucosa, kidney, and lung.
Goldenring JR; Shen KR; Vaughan HD; Modlin IM
J Biol Chem; 1993 Sep; 268(25):18419-22. PubMed ID: 8360141
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor 1 alpha is required for the tumourigenic and aggressive phenotype associated with Rab25 expression in ovarian cancer.
Gomez-Roman N; Sahasrabudhe NM; McGregor F; Chalmers AJ; Cassidy J; Plumb J
Oncotarget; 2016 Apr; 7(16):22650-64. PubMed ID: 26967059
[TBL] [Abstract][Full Text] [Related]
16. Rab25 promotes erlotinib resistance by activating the β1 integrin/AKT/β-catenin pathway in NSCLC.
Wang J; Zhou P; Wang X; Yu Y; Zhu G; Zheng L; Xu Z; Li F; You Q; Yang Q; Zhuo W; Sun J; Chen Z
Cell Prolif; 2019 May; 52(3):e12592. PubMed ID: 30848009
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional analysis of FIP2 binding to the endosome-localised Rab25 GTPase.
Lall P; Horgan CP; Oda S; Franklin E; Sultana A; Hanscom SR; McCaffrey MW; Khan AR
Biochim Biophys Acta; 2013 Dec; 1834(12):2679-90. PubMed ID: 24056041
[TBL] [Abstract][Full Text] [Related]
18. Rab25 suppresses colon cancer cell invasion through upregulating claudin‑7 expression.
Cho SJ; Jeong BY; Yoon SH; Park CG; Lee HY
Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131227
[TBL] [Abstract][Full Text] [Related]
19. Rab25 acts as an oncogene in luminal B breast cancer and is causally associated with Snail driven EMT.
Mitra S; Federico L; Zhao W; Dennison J; Sarkar TR; Zhang F; Takiar V; Cheng KW; Mani S; Lee JS; Mills GB
Oncotarget; 2016 Jun; 7(26):40252-40265. PubMed ID: 27259233
[TBL] [Abstract][Full Text] [Related]
20. Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.
Jeong BY; Cho KH; Jeong KJ; Park YY; Kim JM; Rha SY; Park CG; Mills GB; Cheong JH; Lee HY
Exp Mol Med; 2018 Jan; 50(1):e435. PubMed ID: 29371698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]